The effect of strict segregation on Pseudomonas aeruginosa in cystic fibrosis patients

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Van Mansfeld, Rosa ^a   De Vrankrijker, Angelica ^a   Brimicombe, Roland ^b   Heijerman, Harry ^b   Teding Van Berkhout, Ferdinand ^a   Spitoni, Cristian ^c   Grave, Sanne ^a   Van Der Ent, Cornelis ^a   Wolfs, Tom ^a   Willems, Rob ^a   Bonten, Marc ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CAUSE OF DEATH; CYSTIC FIBROSIS; EPIDEMIC; FEMALE; HUMAN; INFECTION RISK; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POPULATION STRUCTURE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; ADOLESCENT; CHILD; CHRONIC DISEASE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; MICROBIOLOGY; MULTICENTER STUDY; PATIENT ISOLATION; PRESCHOOL CHILD; PSEUDOMONAS INFECTIONS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; PATIENT ISOLATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84975489395     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157189     Document Type: Article

References (43)

1. Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, Hoiby N, et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat Rev Microbiol 2012 Dec; 10(12):841-51. doi: 10.1038/nrmicro2907 PMID: 23147702
2. Cheng K, Smyth RL, Govan JR, Doherty C, Winstanley C, Denning N, et al. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996 Sep 7; 348(9028):639-42. PMID: 8782753
3. Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001 Aug 18; 358(9281):557-8. PMID: 11520529
4. McCallum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet 2001 Aug 18; 358(9281):558-60. PMID: 11520530
5. Armstrong D, Bell S, Robinson M, Bye P, Rose B, Harbour C, et al. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol 2003 May; 41(5):2266-7. PMID: 12734299
6. Fothergill JL, Walshaw MJ, Winstanley C. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur Respir J 2012 Jul; 40(1):227-38. doi: 10.1183/09031936.00204411 PMID: 22323572
7. Aaron SD, Vandemheen KL, Ramotar K, Giesbrecht-Lewis T, Tullis E, Freitag A, et al. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA 2010 Nov 17; 304(19):2145-53. doi: 10.1001/jama.2010.1665 PMID: 21081727
8. Jones AM, Dodd ME, Doherty CJ, Govan JR, Webb AK. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa. Thorax 2002 Nov; 57(11):924-5. PMID: 12403871
9. Al-Aloul M, Crawley J, Winstanley C, Hart CA, Ledson MJ, Walshaw MJ. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 2004 Apr; 59(4):334-6. PMID: 15047956
10. Tingpej P, Elkins M, Rose B, Hu H, Moriarty C, Manos J, et al. Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa. Respirology 2010 Aug; 15(6):923-9. doi: 10.1111/j.1440-1843.2010.01792.x PMID: 20573059
11. Salunkhe P, Smart CH, Morgan JA, Panagea S, Walshaw MJ, Hart CA, et al. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 2005 Jul; 187(14):4908-20. PMID: 15995206
12. Ashish A, Shaw M, Winstanley C, Ledson MJ, Walshaw MJ. Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF) - a cause for concern? J Cyst Fibros 2012 May; 11(3):173-9. doi: 10.1016/j.jcf.2011.11.004 PMID: 22146482
13. The Cystic Fibrosis Trust. Available: http://wwwcysticfibrosis.org.uk/about-cf/living-with-cystic-fibrosis/cross-infection. Accessed 2014.
14. Dutch Institute for Healthcare Improvement. CBO Guideline Diagnosis and Treatment Cystic Fibrosis (Dutch). 2007.
15. Dutch Cystic Fibrosis Foundation website. Available: http://www.ncfs.nl. Accessed 2013.
16. Brimicombe RW, Dijkshoorn L, van der Reijden TJ, Kardoes I, Pitt TL, van den Broek PJ, et al. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros 2008 Jan; 7(1):30-6. PMID: 17532271
17. van Mansfeld R, Willems R, Brimicombe R, Heijerman H, van Berkhout FT, Wolfs T, et al. Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients and age dependency of colonization by various P. aeruginosa sequence types. J Clin Microbiol 2009 Dec; 47(12):4096-101. doi: 10.1128/JCM.01462-09 PMID: 19828746
18. van Mansfeld R, Jongerden I, Bootsma M, Buiting A, Bonten M, Willems R. The population genetics of Pseudomonas aeruginosa isolates from different patient populations exhibits high-level host specificity. PLoS One 2010; 5(10):e13482. doi: 10.1371/journal.pone.0013482 PMID: 20976062
19. de Vrankrijker AM, Brimicombe RW, Wolfs TF, Heijerman HG, van MR, van Berkhout FT, et al. Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients. Clin Microbiol Infect 2011 Mar; 17(3):382-5. doi: 10.1111/j.1469-0691.2010.03295.x PMID: 20807225
20. Jones AM, Dodd ME, Govan JR, Doherty CJ, Smith CM, Isalska BJ, et al. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center. Am J Respir Crit Care Med 2005 Feb 1; 171(3):257-60. PMID: 15542795
21. Griffiths AL, Wurzel DF, Robinson PJ, Carzino R, Massie J. Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic. J Cyst Fibros 2012 Jan; 11(1):49-52. doi: 10.1016/j.jcf.2011.08.005 PMID: 21907639
22. Griffiths AL, Jamsen K, Carlin JB, Grimwood K, Carzino R, Robinson PJ, et al. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med 2005 May 1; 171(9):1020-5. PMID: 15709051
23. Ashish A, Shaw M, Winstanley C, Humphreys L, Walshaw MJ. Halting the spread of epidemic Pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study. JRSM Short Rep 2013 Jan; 4(1):1. doi: 10.1258/shorts.2012.012018 PMID: 23413403
24. Frederiksen B, Koch C, Hoiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999 Sep; 28(3):159-66. PMID: 10495331
25. Wiehlmann L, Cramer N, Ulrich J, Hedtfeld S, Weissbrodt H, Tummler B. Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre-results of a 10-year prospective study. Int J Med Microbiol 2012 Mar; 302(2):69-77. doi: 10.1016/j.ijmm.2011.11.001 PMID: 22196973
26. Taccetti G, Bianchini E, Cariani L, Buzzetti R, Costantini D, Trevisan F, et al. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. Thorax 2012 Oct; 67(10):853-9. PMID: 22379071
27. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993 Mar; 16:5-40. PMID: 8499054
28. Koopman M, Zanen P, Kruitwagen CL, van der Ent CK, Arets HG. Reference values for paediatric pulmonary function testing: The Utrecht dataset. Respir Med 2011 Jan; 105(1):15-23. doi: 10.1016/j.rmed.2010.07.020 PMID: 20889322
29. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003 Mar; 2(1):29-34. PMID: 15463843
30. EUCAST clinical breakpoints. Available: http://www.eucast.org/clinical-breakpoints/. Accessed 2013.
31. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 2004 Dec; 42(12):5644-9. PMID: 15583294
32. Jolley KA, Maiden MC. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 2010; 11:595. doi: 10.1186/1471-2105-11-595 PMID: 21143983
33. Francisco AP, Bugalho M, Ramirez M, Carrico JA. Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach. BMC Bioinformatics 2009; 10:152. doi: 10.1186/1471-2105-10-152 PMID: 19450271
34. Francisco AP, Vaz C, Monteiro PT, Melo-Cristino J, Ramirez M, Carrico JA. PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods. BMC Bioinformatics 2012; 13:87. doi: 10.1186/1471-2105-13-87 PMID: 22568821
35. Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics 1983 Jun; 39(2):499-503. PMID: 6354290
36. Liu G, Liang KY. Sample size calculations for studies with correlated observations. Biometrics 1997 Sep; 53(3):937-47. PMID: 9290224
37. CFBD. Available: http://www.cfbeachdance.nl/. Accessed 2014.
38. Hansen SK, Rau MH, Johansen HK, Ciofu O, Jelsbak L, Yang L, et al. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J 2012 Jan; 6(1):31-45. doi: 10.1038/ismej.2011.83 PMID: 21716309
39. Johansen HK, Aanaes K, Pressler T, Nielsen KG, Fisker J, Skov M, et al. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J Cyst Fibros 2012 Dec; 11(6):525-31. doi: 10.1016/j.jcf.2012.04.011 PMID: 22595452
40. Aanaes K, Johansen HK, Skov M, Buchvald FF, Hjuler T, Pressler T, et al. Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients-can chronic lung infections be postponed? Rhinology 2013 Sep; 51(3):222-30. doi: 10.4193/Rhino12.207 PMID: 23943728
41. Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet 2015 Jan; 16(1):45-56. doi: 10.1038/nrg3849 PMID: 25404111
42. Green DM, Collaco JM, McDougal KE, Naughton KM, Blackman SM, Cutting GR. Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis. J Pediatr 2012 Aug; 161(2):290-5. doi: 10.1016/j.jpeds.2012.01.042 PMID: 22364820
43. Emond MJ, Louie T, Emerson J, Zhao W, Mathias RA, Knowles MR, et al. Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet 2012 Aug; 44(8):886-9. doi: 10.1038/ng.2344 PMID: 22772370